HanchorBio Inc., a global clinical-stage biotechnology company focusing on the discovery and development of innovative immuno-biomedicines to treat a wide…
Browsing: HealthCare
Driving the Medical and Scientific Affairs Division to provide the highest level of patient access and safety Olympus Corporation (Olympus), a…
In the age of early mass dissemination of accessible AI solutions, many specialists and researchers from different scientific, technical and…
Wuhan YZY Biopharma Co., Ltd. (YZY Biopharma or the Company, together with its subsidiaries, the Group, HKG: 2496), is officially…
InSyBio, a leading biotechnology company that has developed a suite of advanced AI tools for biomarker discovery in clinical and…
Amid technological advances in the credentialing industry and a growing global focus on addressing health workforce deployment, CGFNS International announced…
Cats may not be quite as carnivorous as once thought. Whilst biologically carnivorous, cats are increasingly being fed vegan diets…
Offer price between HK$16 and HK$20 per H Share Wuhan YZY Biopharma Co., Ltd. (YZY Biopharma or the Company, together…
Ad Scientiam, a global leader in digital biomarkers, has announced a partnership with Sanofi to launch MS-DETECT, an international, multicenter,…
Clinical Development Program for the Treatment of AD to be Initiated Shortly A Hong Kong-based biopharmaceutical company dedicated to the…
Q&M Dental Group Limited is honoured to announce that it has received the prestigious “Best Investor Relations Award (Gold)” at…
Pivotal Step in Global Commercial Expansion After Successful Launch in the U.S. UroViu Corporation, the developer of a suite of…
Peijia Medical (HKG: 9996), a leading Chinese domestic player in the high-growth transcatheter valve therapeutic and neurointerventional procedural medical device…
Medical aesthetic segment achieved a revenue of RMB194.0 million Returned to high growth Significant R&D investment continued to effectively facilitate…
Group strengthens cell and gene therapy products as well as genetic screening initiatives to enhance future business growth and technological…
Domestic Distribution Business Rebounded Sharply and Core Products Performed Optimistically Kingworld Medicines Group Limited (Kingworld Medicines or the Group, HKG:…
HanchorBio Inc., a global clinical-stage biotechnology company focusing on the discovery and development of innovative immuno-biomedicines, and Shanghai Henlius Biotech,…
First-in-class glucokinase activator (GKA) HuaTangNing (dorzagliatin) was approved in China in September 2022. Since the launch of commercial sales at…
Steadily Advances Innovation and R&D Revenue Climbs to RMB15.28 Billion Adjusted Non-HKFRS Profit Attributable to the Owners of the Parent…
Expanded Hospital Network Healthy Sales of the Company’s Core Products 1H 2023’s Operating Revenue Surged 90% to RMB104 million Ocumension…